WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences


Applied Clinical Trials

WIRB-Copernicus Group announced that it has acquired Alliance Biosciences.

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research, announced that it has acquired Alliance Biosciences. Alliance Biosciences was the leading biosafety and biosecurity consulting firm in the United States and will join WCG’s biosafety division – WCG Biosafety™ – to manage the entire continuum of biosafety oversight, helping to ensure that research involving potentially hazardous agents and vectors complies with the appropriate safety and regulatory requirements from laboratory design and drug discovery through clinical testing and therapeutic application. WCG Biosafety manages more than 200 Institutional Biosafety Committees (IBCs) and has evaluated more than 140 gene transfer clinical and recombinant DNA pre-clinical research protocols to date.


Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.